(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZETAMET

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ZETAMET

ST13

US500000097054481

Class

5

Filing

97054481

Registration

8137565

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

02/11/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

09/30/2021

Registration date

02/10/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/10/2026

Last transaction

02/11/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/25/2025

First use in commerce

09/25/2025

Drawing code

4

Owner type

03

Owner location

Syracuse, NY

Examiner

STEPHENS, BRIA MICHELLE

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Zetagen Therapeutics, Inc.

Representatives

Katherine P. Califa FOLEY & LARDNER LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of metastatic tumors and lesions; Pharmaceuticalsfor destroyinginhibiting or preventing the spread of uncontrolled growth of abnormal tissuesmetastatic tumors and lesions

Publications

History of USPTO decisions and trademark events.

47 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/10/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/10/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/22/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/22/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/13/2026

GNRT

NON-FINAL ACTION E-MAILED

01/13/2026

CNRT

SU - NON-FINAL ACTION - WRITTEN

01/13/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/12/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/12/2026

ALIE

ASSIGNED TO LIE

01/12/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/29/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/29/2025

GNRT

NON-FINAL ACTION E-MAILED

09/29/2025

CNRT

SU - NON-FINAL ACTION - WRITTEN

09/29/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/26/2025

IUAF

USE AMENDMENT FILED

09/25/2025

EISU

TEAS STATEMENT OF USE RECEIVED

09/25/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/12/2025

EX5G

SOU EXTENSION 5 GRANTED

07/11/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/11/2025

EEXT

SOU TEAS EXTENSION RECEIVED

03/24/2025

EXT5

SOU EXTENSION 5 FILED

03/23/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/21/2024

EX4G

SOU EXTENSION 4 GRANTED

08/21/2024

EXT4

SOU EXTENSION 4 FILED

08/21/2024

EEXT

SOU TEAS EXTENSION RECEIVED

08/21/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/21/2024

EX3G

SOU EXTENSION 3 GRANTED

02/20/2024

EXT3

SOU EXTENSION 3 FILED

02/20/2024

EEXT

SOU TEAS EXTENSION RECEIVED

02/20/2024

DOCK

ASSIGNED TO EXAMINER

11/07/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/16/2023

EX2G

SOU EXTENSION 2 GRANTED

09/14/2023

EXT2

SOU EXTENSION 2 FILED

09/14/2023

EEXT

SOU TEAS EXTENSION RECEIVED

09/14/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/11/2023

EX1G

SOU EXTENSION 1 GRANTED

03/09/2023

EXT1

SOU EXTENSION 1 FILED

03/09/2023

EEXT

SOU TEAS EXTENSION RECEIVED

03/09/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/27/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/02/2022

PUBO

PUBLISHED FOR OPPOSITION

08/02/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/13/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/30/2022

DOCK

ASSIGNED TO EXAMINER

06/30/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/28/2021

NWAP

NEW APPLICATION ENTERED

10/04/2021

Continuous trademark protection

Get notified about every new filing that threatens ZETAMET or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.